Status:
COMPLETED
PreDM Clinical Decision Support Intervention
Lead Sponsor:
Northwestern University
Collaborating Sponsors:
AllianceChicago
Erie Family Health Centers
Conditions:
PreDiabetes
Eligibility:
All Genders
18+ years
Brief Summary
Clinical practice guidelines recommend intensive lifestyle interventions and metformin to prevent or delay type 2 diabetes; yet these treatments are not routinely used among the 86 million U.S. adults...
Detailed Description
Eighty six million U.S. adults have prediabetes, and up to 75% of them will eventually develop diabetes. Landmark clinical trials have established that intensive lifestyle interventions (ILI) and metf...
Eligibility Criteria
Inclusion
- age ≥18 years old
- prediabetes
- two weight measurements during the study period
Exclusion
- The primary exclusion criterion is type 2 diabetes.
- The following additional criteria will exclude those in whom treatment is potentially harmful or outcomes assessment may be confounded: serum creatinine \>1.4mg/dL in women and \>1.5mg/dL in men, uncontrolled hypertension (≥180/100mmHg), prior antidiabetic medication orders, and gastric bypass surgery or pregnancy during the evaluation period.
Key Trial Info
Start Date :
February 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 2 2022
Estimated Enrollment :
7424 Patients enrolled
Trial Details
Trial ID
NCT04335331
Start Date
February 27 2020
End Date
September 2 2022
Last Update
February 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern Univeristy
Chicago, Illinois, United States, 60611